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uine hyaline cartilage. The cultured chondrocytes also preserve 
their responsiveness toward local and systemic factors such as 
growth hormone, insulin, PTH and IGF1. Since, cartilage is an 
immuno-privileged tissue; non- autologous cartilage sources may 
also be successfully transplanted. We have shown that mourine 
and porcine-derived cells injected into rats' afflicted (AIA) joints 
replenish the articular lesion with no signs of WBC infiltration. 
Since, prior to differentiation, these cells undergo an intensive 
proliferation phase they can also be transfected. We have also 
shown that osteoprotegerin (OPG)-firstly known for its activity 
as RANK ligand decoy receptor, has direct ameliorative ffects 
on cartilage development. We have shown that OPG transfected 
chondrocytes preserve their typical morphological and functional 
features. 
Conclusions: This model of primary chondrocyte culture, de- 
velop authentic resemblance to hyaline (surfacing) cartilage with 
similar physical and mechanical properties of the original tis- 
sue. These cells can be successfully transplanted into damaged 
joint of a foreign host. Hence, we propose that these primary 
spontaneously-differentiating chondrocytes, from non autologous 
source- can be suitable for replenishment of articular lesions as 
well as vehicle for local application of beneficial cytokines like 
OPG. 
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Aim: To evaluate the effect of TGFI~I on the differentiation to 
chondrogenic phenotype of the F/Strol +, a human bone marrow 
derived mesenchymal stem cell line, cultured in micromass and 
alginate beads. 
Methods: F/Strol+ stem cells were cultured in micromass and 
alginate beads in an incomplete chondrogenic medium (ICM) 
corresponding to DMEM with antibiotics, dexamethasone, ascor- 
bic acid-2-phosphate, proline, sodium pyruvate and a 1:100 dilu- 
tion of Insulin Transferin Selenium plus supplement. A complete 
chondrogenic medium (CCM) was also used, corresponding to 
the ICM medium supplemented with TGFI~I (10 ng/ml). Cultures 
were maintained for 3, 7, 14 and 21 days in a humidified cul- 
ture incubator at 37°C, supplemented with 5% CO2. At harvest, 
one culture from each set was fixed for histological processing 
and all other samples were frozen for RNA extraction. In order 
to determine the step of chondrocyte maturation, we measured 
the expression of type IIA and I collagens and Sox9 transcription 
factor mRNA, as markers of pre-chondrocyte at the fetal stage of 
development and the expression of type liB collagen and aggre- 
can, as markers of mature chondrocyte. The steady-state level of 
mRNA was assessed by real time RT-PCR. Type I and II colla- 
gens, aggrecan and Sox9 protein expression was performed by 
immunohistochemistry analysis. 
Results: Differentiation of F/Strol+ cells was improved in algi- 
nate system as suggested by increased type liB collagen and 
aggrecan mRNA expression during the culture. Furthermore, 
TGFI~I enhanced the differentiation process and allowed to main- 
tain the chondrocyte phenotype. Moreover, our data suggested 
that 3 and 7 days represent a fetal step of the differentiation pro- 
cess since type IIA and I collagens expression was important, 
and that mature chondrocytes appeared after 14 days, as type 
I IA collagen expression completely disappeared. 
Conclusion: Thus, 3D-scaffold and chondrogenic medium are 
sufficient to led to a differentiation of F/Strol+ cell. In the pres- 
ence of TGFI~I, the differentiation process was enhanced. This 
system of culture allowed us to establish a kinetic of the stem 
cells differentiation into chondrogenic lineage. 
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Degenerative arthritis occurs through a variety of mechanisms, 
including joint instability, osteochondral injury, blunt trauma and 
mechanical wear. Recent studies have demonstrated an increase 
in chondrocyte apoptosis in response to mechanical oading of ar- 
ticular cartilage. Furthermore, some investigators have shown an 
ability to decrease the amount of apoptosis that occurs through 
the use of caspase inhibitors in vitro and in vivo. A model of sin- 
gle, sub-fracture, blunt impact to the articular cartilage of rab- 
bit knees has been developed in this lab using a custom made 
spring-loaded impactor. 
The left medial femoral condyle of 21 mature NZW rabbits were 
impacted through a medial parapatellar approach (right left as 
controls Which is control? Right or left?). Impact data were 
recorded directly using a load transducer and LabView 7.0 data 
acquisition and pressure-sensitive paper. The knees from 18 an- 
imals were harvested immediately after impact and incubated in 
growth medium for 1, 3 or 7 days with a non-specific caspase 
inhibitor (which one?), or a sequence-randomized, control pep- 
tide. India ink was applied to each specimen to identify surface 
abnormalities. Specimens were fixed, decalcified, sectioned, and 
stained with Safranin O fast green for histologic analysis, and 
TUNEL assay to detect apoptosis. 
The impact force averaged 695 micro-sec (4- 93.4). Strain values 
averaged 29.3% (4- 8.33). Histologic analysis revealed superfi- 
cial fissuring of all short-term impacted specimens and two spec- 
imens in the 12-week group. An increase in the proportion of cells 
undergoing apotosis was observed at 1,3 and 7 days in impacted 
specimens. Apoptosis rate correlated strongly with the strain of 
the impact over the 7 day duration. No significant difference in 
apoptosis rate was observed in the caspase inhibitor group com- 
pared to the negative controls. Additional characterization of the 
initial cellular and metabolic events that occur in response to this 
impact should further the understanding of mechanisms involved 
in the development of osteoarthritis. 
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Backround: Retinoic acid receptors (RAR) play an important role 
in cell proliferation and differentation, and in regulation of cytokine 
and matrix metalloproteinase production. In osteoarthritis (CA), 
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matrix metalloproteinases play a significant role in cartilage de- 
struction. 
Objective: To determine if RAR-alpha is expressed in the syn- 
ovial membrane (SM) of patients with OA. 
Methods: SM specimens from 17 patients with OA and 14 pa- 
tients with rheumatoid arthritis (RA), obtained during joint re- 
placement, were used in this study. SM cryostat sections were 
stained for RAR-alpha using the ABC indirect immunoperoxi- 
dase method with anti-RAR-alpha rabbit polyclonal antibody (c- 
20; Santa Cruz). The specificity of anti-RAR-alpha polyclonal an- 
tibody was tested with western blotting. 
Results: Immunoreactivity for RAR-alpha was detected in SM 
biopses from all patients with OA and RA. It was present in 
around 30% of mononuclear cells in nodular infiltrates, as well as 
in endothelial cells, synovial lining cells, and fibroblast-like cells. 
Conclusion: The presence of RAR-alpha in SM of patients with 
OA suggests that RAR-alpha may play a role in cartilage destruc- 
tion in OA. 
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Purpose: Transfersome ® carriers are ultradeformable vesicles 
designed to deliver drugs non-invasively through the skin barrier 
to target muscles and joints without being cleared by the cuta- 
neous microcirculation. Ketoprofen is an NSAID analgesic with 
potent additional ocal anti-inflammatory properties. This study 
compared the safety and efficacy of 110 mg of ketoprofen in 
Transfersome ® Gel (IDEA-033) applied dermally twice daily (bid) 
with that of celecoxib (100 mg orally bid) and placebo in treating 
the signs and symptoms of OA of the knee. 
Methods: This 6-week, multicenter, randomized, double-blind, 
double-dummy, parallel-group study was conducted in 397 sub- 
jects with knee OA who were experiencing at least moderate pain 
when not taking analgesic medication. To qualify for the study, 
subjects met the following flare criteria for the index knee at the 
baseline visit: pain with walking of at least 40 mm on the WOMAC 
visual analogue scale (VAS), an increase in pain with walking of 
at least 15 mm on the WOMAC VAS at baseline compared to 
screening, and a physician's global assessment of OA of grade 3 
to 5 and at least a 1 -grade increase from screening. 
Results: 3 co-primary endpoints were defined a priori. In the 
intent-to-treat (ITT) analysis, for the WOMAC pain subscale, 
both IDEA-033 (p= 0.0041) and celecoxib (p= 0.0004) showed 
a statistically significant improvement in the least squares (LS) 
mean change from baseline at Week 6 vs. placebo. For the 
WOMAC physical function subscale, celecoxib showed a signifi- 
cant (p= 0.0100) improvement in the LS mean change from base- 
line at Week 6 vs. placebo; the improvement for IDEA-033 vs. 
placebo approached statistical significance (p=0.077). For Patient 
Global Assessment, both IDEA-033 (p= 0.0015) and celecoxib 
(p= 0.0145) showed a statistically significantly higher response 
to therapy at Week 6 for the LS mean values vs. placebo. Anal- 
ysis of the primary efficacy endpoints by study week proved that 
both IDEA-033 and celecoxib were associated with progressive 
improvement over the six-week study period. The results of the 
per-protocol analysis were generally consistent with the ITT anal- 
ysis; however, for the WOMAC physical function subscale, the 
improvement after 6 weeks with IDEA-033 was significantly (p= 
0.0118) greater than with placebo. IDEA-033 was well tolerated. 
Overall, 53.6% of subjects treated with IDEA-033, 50.0% of sub- 
jects treated with celecoxib, and 48.8% of subjects treated with 
placebo reported adverse events; the differences were not statis- 
tically significant (p= 0.7116). 
Conclusions: IDEA-033 was superior to placebo for 2 of the 3 
primary efficacy measures in the ITT population and for all 3 pri- 
mary efficacy measures in the per-protocol population. The study 
medications were generally well tolerated. The severity and na- 
ture of adverse events were generally similar among groups. 
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Aim: Cathepsin K is expressed in articular cartilage and synovial 
fibroblasts and has the capacity to degrade several bone and car- 
tilage matrix components including collagen types 1,2 and aggre- 
can indicating a potential role of cathepsin K in OA pathology. We 
have identified SB-553484 as an orally available potent inhibitor 
of dog cathepsin K (Ki = 200 pM) that exhibits 4-80 fold selectivity 
over other cathepsins uch as L, S and B. This study investigated 
the effects of SB-553484 on chondroprotection i  the dog menis- 
cectomy model of OA. 
Methods: Female beagle dogs had unilateral partial medial 
meniscectomy on the left knee and were treated with vehicle 
(n=20) or SB-553484, po, bid, at 50 mg/kg (n=20) beginning 1 
day before and continuing for 4 weeks post surgery. Left knees 
were evaluated 4 weeks post surgery for effects of treatment on 
gross and microscopic histological changes. Parameters for the 
groups were com pared using the Student's t-test with significance 
set at p_< 0.05. 
Results: All dogs tolerated the treatment and exhibited normal 
activity and appetite. Typical degenerative changes characterized 
by the presence of focal, well circumscribed lesions of cartilage 
degeneration were present on the medial tibias and to lesser 
extent on femoral condyles of all dogs in the vehicle control 
group. Subjective gross cartilage degeneration scores were de- 
creased significantly by 29% in SB-553484 treated dogs. Calcu- 
lated (length X width X depth) gross tibial scores were decreased 
significantly by 46% in SB-553484 treated dogs. Combined sub- 
jective tibial and femoral cartilage degeneration scores were de- 
creased significantly by 28% in SB-553484 treated dogs whereas 
calculated summed scores were decreased non-significantly by 
39%. Histopathological evaluation of the vehicle-treated ogs re- 
vealed typical degenerative changes with the most severe tibial 
lesions in the mid-tibia. Summed tibial cartilage degeneration de- 
creased significantly by 21% in the SB-553484 group. Inhibition 
of cartilage degeneration in 4 zones from outside (1) to far in- 
side (4) was significant for zone 1 (32%) and 16-22% for all other 
zones. Significant tibial cartilage degeneration width was non- 
significantly decreased by 21%. Overall depth ratio of any tibial 
matrix change was decreased significantly by 28% and the range 
of decrease across the 4 zones was 17-53%. 
Conclusion: In summary, this study demonstrated mild to mod- 
erate beneficial effects of oral treatment with SB-553484 on gross 
and histopathological parameters measured in meniscectomy in- 
duced cartilage degeneration in beagle dogs. The data suggest 
that targeting cathepsin K may represent a valid strategy for phar- 
maceutical intervention in osteoarthritis. 
